Transparency

United Kingdom Disclosure of Transfers of Values

Servier is an independent research foundation with no shareholders and as such revenue from the sale of our medicines is directly invested back into the research and development of our future treatments.

Servier is proud to work with UK Healthcare Professionals (Doctors, Nurses, and Pharmacists) to help patients get the life enhancing medicines they need and fully support a transparent culture. Such collaborations are recognition of the world class medical expertise we have available in this country and facilitate the sharing of best practice across the UK and around the world. As a global company, we see this as part of our ethical responsibility.

The advice we receive from clinical experts ensures that our medicines of today and tomorrow truly meet the needs of patients.  The disclosure of transfers of values to Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs) is part of the transparency initiative developed by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Association of the British Pharmaceutical Industry (ABPI). Servier adheres and fully supports the objectives promoted through this self-regulatory initiative and believes the outcome of this publication will contribute to a better insight into our interactions.

All of Servier's Transfers of Values to HCPs and HCOs (along with our methological note) can be found on the ABPI's publically searchable database Disclosure UK accessible on their website.

The ABPI also has a 'resources' page containing information for use by HCPs and HCOs to help them understand how Disclosure UK works.

If you are a healthcare professional with an enquiry regarding a payment you have received from Servier, or your details in the database, please email datamanagementUK@servier.com

If you would like to contact Servier Laboratories Ltd (UK), or to find more information on the publication made by Servier in other countries please use the appropriate link below:

Press/Media enquiry

General enquiry

Other Countries

 

UK14WEB0013b(1)a(1)  DoP: July 2018